HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of intra-arterial versus intravenous 5-fluorouracil administration on epidermal squamous cell carcinoma in sheep.

Abstract
Clinical evidence that intra-arterial chemotherapy is more effective in regressing head and neck cancers than equivalent intravenous doses is lacking. Intra-arterial versus intravenous 5-fluorouracil infusion was compared in a naturally occurring, auricular epidermal squamous cell cancer in sheep. Of 18 lesions infused intra-arterially and of 18 infused intravenously with the same dose, 39 and 11%, respectively responded objectively (over 50% regression); mean (S.E.) tumour volume reduction was 37(23) and 18(22)%, respectively. There was a statistically significant difference in the mean tumour response and in numbers of tumours regressing by at least 40% of tumour volume (50% of intra-arterial treated tumours compared with 11% of intravenous treated lesions) after the 16 day total infusion time in favour of intra-arterial treatment. Technically, the intra-arterial route in this model was an improvement on previous small animal models. These findings lend support to the need for continuing clinical study of intra-arterial infusion.
AuthorsG J Harker, F O Stephens
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 28A Issue 8-9 Pg. 1437-41 ( 1992) ISSN: 0959-8049 [Print] England
PMID1515266 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Fluorouracil
Topics
  • Animals
  • Carcinoma, Squamous Cell (drug therapy)
  • Disease Models, Animal
  • Drug Administration Schedule
  • Ear Neoplasms (drug therapy)
  • Fluorouracil (administration & dosage, therapeutic use)
  • Infusions, Intra-Arterial
  • Infusions, Intravenous
  • Sheep
  • Skin Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: